Cross-neutralization of four paramyxoviruses by a human monoclonal antibody (Q42275949)

19 October 2017

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody (English)

1 reference

19 October 2017

1 reference

1 reference

5

1 reference

19 October 2017

14

1 reference

19 October 2017

13

Federica Sallusto

0 references

Antonio Lanzavecchia

15

object named as

Antonio Lanzavecchia

1 reference

19 October 2017

Barbara Guarino

7

0 references

Siro Bianchi

object named as

Siro Bianchi

2

0 references

Elena Percivalle

12

object named as

Elena Percivalle

1 reference

19 October 2017

6

Gloria Agatic

1 reference

19 October 2017

4

Andrea Minola

1 reference

19 October 2017

9

Jessica Marcandalli

1 reference

19 October 2017

3

Fabrizia Vanzetta

1 reference

19 October 2017

Davide Corti

1

1 reference

19 October 2017

Chiara Silacci

8

1 reference

19 October 2017

Benjamin J Marsland

10

1 reference

19 October 2017

Antonio Piralla

11

1 reference

19 October 2017

language of work or name

English

0 references

publication date

18 August 2013

1 reference

19 October 2017

1 reference

19 October 2017

501

1 reference

19 October 2017

439-443

1 reference

19 October 2017

7467

1 reference

https://scigraph.springernature.com/pub.10.1038/nature12442

19 October 2017

0 references

cites work

Broadly neutralizing antiviral antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

The burden of respiratory syncytial virus infection in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Burden of human metapneumovirus infection in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Respiratory syncytial virus infection in elderly and high-risk adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Palivizumab-resistant human respiratory syncytial virus infection in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Natural polymorphisms and resistance-associated mutations in the fusion protein of respiratory syncytial virus (RSV): effects on RSV susceptibility to palivizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Respiratory syncytial virus escape mutant derived in vitro resists palivizumab prophylaxis in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

The role of IFN in respiratory syncytial virus pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Animal models for studying respiratory syncytial virus infection and its long term effects on lung function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Human metapneumovirus in severe respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

IMGT, the international ImMunoGeneTics information system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

Structural aspects of antibody-antigen interaction revealed through small random peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE12442

The microbiology of asthma

21 January 2018

1 reference

12 December 2020

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

12 December 2020

Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function

1 reference

12 December 2020

Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1038/NATURE12442

1 reference

Dimensions Publication ID

19 October 2017

0 references

1 reference